Apellis Pharmaceuticals CEO Cedric Francois' 2020 pay jumps 117% to $9.3M
Apellis Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 22, 2021
Apellis Pharmaceuticals reported fiscal year 2020 executive compensation information on April 22, 2021.
In 2020, five executives at Apellis Pharmaceuticals received on average a compensation package of $4.3M, a 58% increase compared to previous year.
Average pay of disclosed executives at Apellis Pharmaceuticals
Cedric Francois, Chief Executive Officer, received $9.3M in total, which increased by 117% compared to 2019. 72% of Francois' compensation, or $6.7M, was in option awards. Francois also received $430K in bonus, $619K in salary, as well as $1.5M in stock awards.
Timothy Sullivan, Chief Financial Officer, received a compensation package of $3.5M, which increased by 103% compared to previous year. 65% of the compensation package, or $2.3M, was in option awards.
Nur Nicholson, Chief Technical Operations Officer, earned $3M in 2020.
Pascal Deschatelets, Chief Scientific Officer, received $2.9M in 2020, which increases by 60% compared to 2019.
Adam Townsend, Chief Commercial Officer, earned $2.9M in 2020.
Related executives
Cedric Francois
Apellis Pharmaceuticals
Chief Executive Officer
Timothy Sullivan
Apellis Pharmaceuticals
Chief Financial Officer
Pascal Deschatelets
Apellis Pharmaceuticals
Chief Scientific Officer
Nur Nicholson
Apellis Pharmaceuticals
Chief Technical Operations Officer
Adam Townsend
Apellis Pharmaceuticals
Chief Commercial Officer
You may also like
Source: SEC filing on April 22, 2021.